AACR Chief Philanthropic Officer Mitch Stoller to Receive 2024 Change Our Future Game Changer Award
Stoller will be recognized tonight at the 4th annual Sneaker Ball, hosted by former Eagle Rodney McLeod Jr. and...
Search/Filter
Loading...
Among Cancer Survivors, LGBTQ+ Individuals Report Higher Prevalence of Chronic Health Conditions, Disabilities, Other Limitations
Transgender or gender non-conforming cancer survivors had higher odds of most conditions compared to cisgender cancer survivors PHILADELPHIA –...
Trametinib Shows Promise for Children with Relapsed or Refractory JMML
PHILADELPHIA – The MEK inhibitor trametinib (Mekinist) was an effective treatment for pediatric patients with relapsed or refractory juvenile...
HPV Testing for Cervical Cancer May Be Safe at Longer Intervals Than What Current Guidelines Recommend
HPV testing eight years after a negative result instead of the recommended five was found comparable to standard cytology...
AACR Releases Cancer Disparities Progress Report 2024
Report features latest statistics and nine compelling patient stories PHILADELPHIA — The American Association for Cancer Research (AACR) today...
Culturally Sensitive Video Targeting Black Men May Help Increase Awareness About Prostate Cancer
SAN DIEGO – A video designed to educate Black men about prostate cancer resulted in 97% of surveyed participants...
Proteogenomic Signatures May Help Identify Risk of Prostate Cancer Progression in Patients with African and European Ancestries
SAN DIEGO – Certain proteogenomic signatures in the prostate cancers of men of African and European ancestries were associated...
AZD1390 With Radiotherapy Shows Manageable Safety Profile and Preliminary Efficacy for Patients with Glioblastoma in Phase I Trial
SAN DIEGO – AZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, demonstrated a manageable safety profile in both recurrent...
Artificial Intelligence Analysis of DNA Fragmentomes and Protein Biomarkers Noninvasively Detects Ovarian Cancer
SAN DIEGO – A blood-based machine learning assay that combines cell-free DNA (cfDNA) fragment patterns and levels of the...
Investigational Personalized Vaccine Provides Clinical Benefit for Some Patients with Resected Head and Neck Cancers
SAN DIEGO – TG4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease...